Sumitomo Mitsui Ds Asset Management Company, LTD Biomarin Pharmaceutical Inc Call Options Transaction History
Sumitomo Mitsui Ds Asset Management Company, LTD
- $10.9 Billion
- Q2 2025
Call Options
0 transactions
| Quarter | Operation | Price Per call | calls change | calls Held | SEC Form |
|---|
Others Institutions Holding BMRN
# of Institutions
665Shares Held
184MCall Options Held
1.24MPut Options Held
957K-
Black Rock Inc. New York, NY22.7MShares$1.36 Billion0.04% of portfolio
-
Vanguard Group Inc Valley Forge, PA19MShares$1.13 Billion0.03% of portfolio
-
Primecap Management CO Pasadena, CA17.8MShares$1.06 Billion1.06% of portfolio
-
Dodge & Cox San Francisco, CA15MShares$892 Million0.65% of portfolio
-
Viking Global Investors LP10.8MShares$644 Million2.55% of portfolio
About BIOMARIN PHARMACEUTICAL INC
- Ticker BMRN
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 185,824,000
- Market Cap $11.1B
- Description
- BioMarin Pharmaceutical Inc. develops and commercializes therapies for people with serious and life-threatening rare diseases and medical conditions. Its commercial products include Vimizim, an enzyme replacement therapy for the treatment of mucopolysaccharidosis (MPS) IV type A, a lysosomal storage disorder; Naglazyme, a recombinant form of N-a...